{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:37:25Z","timestamp":1780393045158,"version":"3.54.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00125-015-3722-5","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T06:45:02Z","timestamp":1438843502000},"page":"2459-2468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["The new biology of diabetes"],"prefix":"10.1007","volume":"58","author":[{"given":"Utpal B.","family":"Pajvani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Accili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"3722_CR1","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.2337\/diabetes.53.7.1633","volume":"53","author":"D Accili","year":"2004","unstructured":"Accili D (2004) Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes 53:1633\u20131642","journal-title":"Diabetes"},{"key":"3722_CR2","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427\u20132443","journal-title":"N Engl J Med"},{"key":"3722_CR3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129\u2013139","journal-title":"N Engl J Med"},{"key":"3722_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(25)00587-7","volume":"91","author":"KK Chen","year":"1947","unstructured":"Chen KK, Anderson RC (1947) The toxicity and general pharmacology of N1-p-chlorophenyl-N5-isopropyl biguanide. J Pharmacol Exp Ther 91:157\u2013160","journal-title":"J Pharmacol Exp Ther"},{"key":"3722_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.med.57.110104.115624","volume":"57","author":"LL Baggio","year":"2006","unstructured":"Baggio LL, Drucker DJ (2006) Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57:265\u2013281","journal-title":"Annu Rev Med"},{"issue":"Suppl 2","key":"3722_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2010.01296.x","volume":"12","author":"D Accili","year":"2010","unstructured":"Accili D, Ahren B, Boitard C, Cerasi E, Henquin JC, Seino S (2010) What ails the beta-cell? Diabetes Obes Metab 12(Suppl 2):1\u20133","journal-title":"Diabetes Obes Metab"},{"key":"3722_CR7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili D, Arden KC (2004) FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421\u2013426","journal-title":"Cell"},{"key":"3722_CR8","doi-asserted-by":"crossref","first-page":"26861","DOI":"10.1074\/jbc.M110.134023","volume":"285","author":"RA Haeusler","year":"2010","unstructured":"Haeusler RA, Han S, Accili D (2010) Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. J Biol Chem 285:26861\u201326868","journal-title":"J Biol Chem"},{"key":"3722_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2005.08.004","volume":"2","author":"YI Kitamura","year":"2005","unstructured":"Kitamura YI, Kitamura T, Kruse JP et al (2005) FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2:153\u2013163","journal-title":"Cell Metab"},{"key":"3722_CR10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223\u20131234","journal-title":"Cell"},{"key":"3722_CR11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1092952","volume":"302","author":"MF White","year":"2003","unstructured":"White MF (2003) Insulin signaling in health and disease. Science 302:1710\u20131711","journal-title":"Science"},{"key":"3722_CR12","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1073\/pnas.92.4.983","volume":"92","author":"DL Rothman","year":"1995","unstructured":"Rothman DL, Magnusson I, Cline G et al (1995) Decreased muscle glucose transport\/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 92:983\u2013987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3722_CR13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2337\/diab.45.11.1644","volume":"45","author":"BB Kahn","year":"1996","unstructured":"Kahn BB (1996) Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45:1644\u20131654","journal-title":"Diabetes"},{"key":"3722_CR14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(51)91476-6","volume":"2","author":"AG Bearn","year":"1951","unstructured":"Bearn AG, Billing BH, Sherlock S (1951) Hepatic glucose output and hepatic insulin sensitivity in diabetes mellitus. Lancet 2:698\u2013701","journal-title":"Lancet"},{"key":"3722_CR15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.2166335","volume":"249","author":"RM O\u2019Brien","year":"1990","unstructured":"O\u2019Brien RM, Lucas PC, Forest CD, Magnuson MA, Granner DK (1990) Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. Science 249:533\u2013537","journal-title":"Science"},{"key":"3722_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/334494a0","volume":"334","author":"KK Yamamoto","year":"1988","unstructured":"Yamamoto KK, Gonzalez GA, Biggs WH 3rd, Montminy MR (1988) Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494\u2013498","journal-title":"Nature"},{"key":"3722_CR17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","volume":"6","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D (2007) Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6:208\u2013216","journal-title":"Cell Metab"},{"key":"3722_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","volume":"8","author":"XC Dong","year":"2008","unstructured":"Dong XC, Copps KD, Guo S et al (2008) Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65\u201376","journal-title":"Cell Metab"},{"key":"3722_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cmet.2008.05.007","volume":"8","author":"N Kubota","year":"2008","unstructured":"Kubota N, Kubota T, Itoh S et al (2008) Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab 8:49\u201364","journal-title":"Cell Metab"},{"key":"3722_CR20","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1152\/ajpendo.00156.2003","volume":"285","author":"J Altomonte","year":"2003","unstructured":"Altomonte J, Richter A, Harbaran S et al (2003) Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab 285:E718\u2013E728","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3722_CR21","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1172\/JCI200216857","volume":"110","author":"T Kitamura","year":"2002","unstructured":"Kitamura T, Nakae J, Kitamura Y et al (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110:1839\u20131847","journal-title":"J Clin Invest"},{"key":"3722_CR22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.278.5341.1319","volume":"278","author":"K Lin","year":"1997","unstructured":"Lin K, Dorman JB, Rodan A, Kenyon C (1997) daf-16: An HNF-3\/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278:1319\u20131322","journal-title":"Science"},{"key":"3722_CR23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/40194","volume":"389","author":"S Ogg","year":"1997","unstructured":"Ogg S, Paradis S, Gottlieb S et al (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994\u2013999","journal-title":"Nature"},{"key":"3722_CR24","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","volume":"5","author":"RA Haeusler","year":"2014","unstructured":"Haeusler RA, Hartil K, Vaitheesvaran B et al (2014) Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nat Commun 5:5190","journal-title":"Nat Commun"},{"key":"3722_CR25","doi-asserted-by":"crossref","first-page":"35245","DOI":"10.1074\/jbc.C110.175851","volume":"285","author":"RA Haeusler","year":"2010","unstructured":"Haeusler RA, Kaestner KH, Accili D (2010) FoxOs function synergistically to promote glucose production. J Biol Chem 285:35245\u201335248","journal-title":"J Biol Chem"},{"key":"3722_CR26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cmet.2014.08.012","volume":"20","author":"JY Kim-Muller","year":"2014","unstructured":"Kim-Muller JY, Zhao S, Srivastava S et al (2014) Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metab 20:593\u2013602","journal-title":"Cell Metab"},{"key":"3722_CR27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm1392","volume":"12","author":"T Kitamura","year":"2006","unstructured":"Kitamura T, Feng Y, Kitamura YI et al (2006) Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med 12:534\u2013540","journal-title":"Nat Med"},{"key":"3722_CR28","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm.2026","volume":"15","author":"L Plum","year":"2009","unstructured":"Plum L, Lin HV, Dutia R et al (2009) The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med 15:1195\u20131201","journal-title":"Nat Med"},{"key":"3722_CR29","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.cell.2012.04.032","volume":"149","author":"H Ren","year":"2012","unstructured":"Ren H, Orozco IJ, Su Y et al (2012) FoxO1 target Gpr17 activates AgRP neurons to regulate food intake. Cell 149:1314\u20131326","journal-title":"Cell"},{"key":"3722_CR30","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.M600272200","volume":"281","author":"W Zhang","year":"2006","unstructured":"Zhang W, Patil S, Chauhan B et al (2006) FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 281:10105\u201310117","journal-title":"J Biol Chem"},{"key":"3722_CR31","doi-asserted-by":"crossref","first-page":"13296","DOI":"10.1074\/jbc.C800241200","volume":"284","author":"P Chakrabarti","year":"2009","unstructured":"Chakrabarti P, Kandror KV (2009) FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem 284:13296\u201313300","journal-title":"J Biol Chem"},{"key":"3722_CR32","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1172\/JCI23126","volume":"115","author":"M Potente","year":"2005","unstructured":"Potente M, Urbich C, Sasaki K et al (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115:2382\u20132392","journal-title":"J Clin Invest"},{"key":"3722_CR33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2012.01.018","volume":"15","author":"K Tsuchiya","year":"2012","unstructured":"Tsuchiya K, Tanaka J, Shuiqing Y et al (2012) FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab 15:372\u2013381","journal-title":"Cell Metab"},{"key":"3722_CR34","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/MCB.01622-08","volume":"29","author":"T Kitamura","year":"2009","unstructured":"Kitamura T, Kitamura YI, Kobayashi M et al (2009) Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1. Mol Cell Biol 29:4417\u20134430","journal-title":"Mol Cell Biol"},{"key":"3722_CR35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cmet.2014.03.010","volume":"19","author":"Z Wang","year":"2014","unstructured":"Wang Z, York NW, Nichols CG, Remedi MS (2014) Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab 19:872\u2013882","journal-title":"Cell Metab"},{"key":"3722_CR36","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","volume":"108","author":"J Nakae","year":"2001","unstructured":"Nakae J, Kitamura T, Silver DL, Accili D (2001) The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359\u20131367","journal-title":"J Clin Invest"},{"key":"3722_CR37","doi-asserted-by":"crossref","first-page":"20589","DOI":"10.1074\/jbc.M412357200","volume":"280","author":"D Frescas","year":"2005","unstructured":"Frescas D, Valenti L, Accili D (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280:20589\u201320595","journal-title":"J Biol Chem"},{"key":"3722_CR38","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db09-1625","volume":"59","author":"CJ Ramnanan","year":"2010","unstructured":"Ramnanan CJ, Edgerton DS, Rivera N et al (2010) Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes 59:1302\u20131311","journal-title":"Diabetes"},{"key":"3722_CR39","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/db11-1462","volume":"61","author":"AV Matveyenko","year":"2012","unstructured":"Matveyenko AV, Liuwantara D, Gurlo T et al (2012) Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes 61:2269\u20132279","journal-title":"Diabetes"},{"key":"3722_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2011.06.003","volume":"14","author":"HV Lin","year":"2011","unstructured":"Lin HV, Accili D (2011) Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 14:9\u201319","journal-title":"Cell Metab"},{"key":"3722_CR41","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1210\/en.2006-0541","volume":"147","author":"S Qu","year":"2006","unstructured":"Qu S, Altomonte J, Perdomo G et al (2006) Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology 147:5641\u20135652","journal-title":"Endocrinology"},{"key":"3722_CR42","first-page":"2464","volume":"116","author":"M Matsumoto","year":"2006","unstructured":"Matsumoto M, Han S, Kitamura T, Accili D (2006) Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest 116:2464\u20132472","journal-title":"J Clin Invest"},{"key":"3722_CR43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2011.09.001","volume":"14","author":"M Wan","year":"2011","unstructured":"Wan M, Leavens KF, Saleh D et al (2011) Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab 14:516\u2013527","journal-title":"Cell Metab"},{"key":"3722_CR44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nm.2686","volume":"18","author":"M Lu","year":"2012","unstructured":"Lu M, Wan M, Leavens KF et al (2012) Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 18:388\u2013395","journal-title":"Nat Med"},{"key":"3722_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/cac8045c-5526-4cf6-81cc-32038949c12a","volume":"8","author":"X Xiong","year":"2013","unstructured":"Xiong X, Tao R, DePinho RA, Dong XC (2013) Deletion of hepatic FoxO1\/3\/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis. PLoS One 8:e74340","journal-title":"PLoS One"},{"key":"3722_CR46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53:1270\u20131287","journal-title":"Diabetologia"},{"key":"3722_CR47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589","journal-title":"N Engl J Med"},{"key":"3722_CR48","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diacare.25.3.476","volume":"25","author":"JJ Caro","year":"2002","unstructured":"Caro JJ, Ward AJ, O\u2019Brien JA (2002) Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25:476\u2013481","journal-title":"Diabetes Care"},{"key":"3722_CR49","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMp1008233","volume":"363","author":"CJ Rosen","year":"2010","unstructured":"Rosen CJ (2010) Revisiting the rosiglitazone story\u2014lessons learned. N Engl J Med 363:803\u2013806","journal-title":"N Engl J Med"},{"key":"3722_CR50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","volume":"14","author":"KE Bornfeldt","year":"2011","unstructured":"Bornfeldt KE, Tabas I (2011) Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 14:575\u2013585","journal-title":"Cell Metab"},{"key":"3722_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.411","volume":"63","author":"ML Massa","year":"2011","unstructured":"Massa ML, Gagliardino JJ, Francini F (2011) Liver glucokinase: an overview on the regulatory mechanisms of its activity. IUBMB Life 63:1\u20136","journal-title":"IUBMB Life"},{"key":"3722_CR52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/nm.3259","volume":"19","author":"UB Pajvani","year":"2013","unstructured":"Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, Accili D (2013) Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med 19:1054\u20131060","journal-title":"Nat Med"},{"key":"3722_CR53","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/en.2011-1527","volume":"153","author":"K Zhang","year":"2012","unstructured":"Zhang K, Li L, Qi Y et al (2012) Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. Endocrinology 153:631\u2013646","journal-title":"Endocrinology"},{"key":"3722_CR54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2011.11.010","volume":"15","author":"RA Haeusler","year":"2012","unstructured":"Haeusler RA, Pratt-Hyatt M, Welch CL, Klaassen CD, Accili D (2012) Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metab 15:65\u201374","journal-title":"Cell Metab"},{"key":"3722_CR55","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1074\/jbc.M110.201061","volume":"286","author":"R Tao","year":"2011","unstructured":"Tao R, Wei D, Gao H, Liu Y, DePinho RA, Dong XC (2011) Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J Biol Chem 286:14681\u201314690","journal-title":"J Biol Chem"},{"key":"3722_CR56","doi-asserted-by":"crossref","first-page":"E1126","DOI":"10.1210\/jc.2010-2017","volume":"96","author":"A Peter","year":"2011","unstructured":"Peter A, Stefan N, Cegan A et al (2011) Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab 96:E1126\u2013E1130","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-17214-4_15","volume":"203","author":"FM Matschinsky","year":"2011","unstructured":"Matschinsky FM, Zelent B, Doliba NM et al (2011) Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects. Handb Exp Pharmacol 203:357\u2013401","journal-title":"Handb Exp Pharmacol"},{"key":"3722_CR58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/23716","volume":"400","author":"A Apelqvist","year":"1999","unstructured":"Apelqvist A, Li H, Sommer L et al (1999) Notch signalling controls pancreatic cell differentiation. Nature 400:877\u2013881","journal-title":"Nature"},{"key":"3722_CR59","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra0906948","volume":"363","author":"MI McCarthy","year":"2010","unstructured":"McCarthy MI (2010) Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339\u20132350","journal-title":"N Engl J Med"},{"key":"3722_CR60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nm.2378","volume":"17","author":"UB Pajvani","year":"2011","unstructured":"Pajvani UB, Shawber CJ, Samuel VT et al (2011) Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med 17:961\u2013967","journal-title":"Nat Med"},{"key":"3722_CR61","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.2337\/db13-0769","volume":"62","author":"L Valenti","year":"2013","unstructured":"Valenti L, Mendoza RM, Rametta R et al (2013) Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease. Diabetes 62:4052\u20134062","journal-title":"Diabetes"},{"key":"3722_CR62","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920109787315060","volume":"10","author":"B Purow","year":"2009","unstructured":"Purow B (2009) Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol 10:154\u2013160","journal-title":"Curr Pharm Biotechnol"},{"key":"3722_CR63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nm.3615","volume":"20","author":"P Bi","year":"2014","unstructured":"Bi P, Shan T, Liu W et al (2014) Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity. Nat Med 20:911\u2013918","journal-title":"Nat Med"},{"key":"3722_CR64","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1073\/pnas.1311121111","volume":"111","author":"X Liu","year":"2014","unstructured":"Liu X, Chhipa RR, Pooya S et al (2014) Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Natl Acad Sci U S A 111:E435\u2013E444","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3722_CR65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11892-009-0087-5","volume":"10","author":"B Staels","year":"2010","unstructured":"Staels B, Handelsman Y, Fonseca V (2010) Bile acid sequestrants for lipid and glucose control. Curr Diab Rep 10:70\u201377","journal-title":"Curr Diab Rep"},{"key":"3722_CR66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","volume":"284","author":"M Makishima","year":"1999","unstructured":"Makishima M, Okamoto AY, Repa JJ et al (1999) Identification of a nuclear receptor for bile acids. Science 284:1362\u20131365","journal-title":"Science"},{"key":"3722_CR67","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","volume":"62","author":"RA Haeusler","year":"2013","unstructured":"Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E (2013) Human insulin resistance is associated with increased plasma levels of 12alpha-hydroxylated bile acids. Diabetes 62:4184\u20134191","journal-title":"Diabetes"},{"key":"3722_CR68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","volume":"104","author":"C Weyer","year":"1999","unstructured":"Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787\u2013794","journal-title":"J Clin Invest"},{"key":"3722_CR69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2010.04.009","volume":"11","author":"E Ferrannini","year":"2010","unstructured":"Ferrannini E (2010) The stunned beta cell: a brief history. Cell Metab 11:349\u2013352","journal-title":"Cell Metab"},{"key":"3722_CR70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2013.05.018","volume":"18","author":"M Prentki","year":"2013","unstructured":"Prentki M, Matschinsky FM, Madiraju SR (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18:162\u2013185","journal-title":"Cell Metab"},{"key":"3722_CR71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2337\/diab.45.6.711","volume":"45","author":"MC Harbeck","year":"1996","unstructured":"Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL (1996) Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells. Diabetes 45:711\u2013717","journal-title":"Diabetes"},{"key":"3722_CR72","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","volume":"391","author":"DJ Withers","year":"1998","unstructured":"Withers DJ, Sanchez-Gutierrez J, Towery H et al (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900\u2013904","journal-title":"Nature"},{"key":"3722_CR73","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0092-8674(00)80546-2","volume":"96","author":"RN Kulkarni","year":"1999","unstructured":"Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329\u2013339","journal-title":"Cell"},{"key":"3722_CR74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/diab.45.2.223","volume":"45","author":"FM Matschinsky","year":"1996","unstructured":"Matschinsky FM (1996) Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 45:223\u2013241","journal-title":"Diabetes"},{"key":"3722_CR75","doi-asserted-by":"crossref","first-page":"16530","DOI":"10.1074\/jbc.M109.092593","volume":"285","author":"ML Odegaard","year":"2010","unstructured":"Odegaard ML, Joseph JW, Jensen MV et al (2010) The mitochondrial 2-oxoglutarate carrier is part of a metabolic pathway that mediates glucose- and glutamine-stimulated insulin secretion. J Biol Chem 285:16530\u201316537","journal-title":"J Biol Chem"},{"key":"3722_CR76","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.283.5404.981","volume":"283","author":"K Eto","year":"1999","unstructured":"Eto K, Tsubamoto Y, Terauchi Y et al (1999) Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 283:981\u2013985","journal-title":"Science"},{"key":"3722_CR77","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1074\/jbc.272.30.18572","volume":"272","author":"F Schuit","year":"1997","unstructured":"Schuit F, de Vos A, Farfari S et al (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572\u201318579","journal-title":"J Biol Chem"},{"key":"3722_CR78","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.celrep.2014.09.030","volume":"9","author":"G Gheni","year":"2014","unstructured":"Gheni G, Ogura M, Iwasaki M et al (2014) Glutamate acts as a key signal linking glucose metabolism to incretin\/cAMP action to amplify insulin secretion. Cell Rep 9:661\u2013673","journal-title":"Cell Rep"},{"key":"3722_CR79","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/diabetes.54.7.2132","volume":"54","author":"R Ivarsson","year":"2005","unstructured":"Ivarsson R, Quintens R, Dejonghe S et al (2005) Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54:2132\u20132142","journal-title":"Diabetes"},{"key":"3722_CR80","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00218.2004","volume":"288","author":"MJ MacDonald","year":"2005","unstructured":"MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA (2005) Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am J Physiol Endocrinol Metab 288:E1\u2013E15","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3722_CR81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1074\/jbc.M606118200","volume":"282","author":"J Buteau","year":"2007","unstructured":"Buteau J, Shlien A, Foisy S, Accili D (2007) Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. J Biol Chem 282:287\u2013293","journal-title":"J Biol Chem"},{"key":"3722_CR82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2337\/diabetes.49.5.677","volume":"49","author":"DE Kelley","year":"2000","unstructured":"Kelley DE, Mandarino LJ (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677\u2013683","journal-title":"Diabetes"},{"key":"3722_CR83","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1101\/gad.227785.113","volume":"27","author":"S Puri","year":"2013","unstructured":"Puri S, Akiyama H, Hebrok M (2013) VHL-mediated disruption of Sox9 activity compromises beta-cell identity and results in diabetes mellitus. Genes Dev 27:2563\u20132575","journal-title":"Genes Dev"},{"key":"3722_CR84","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.celrep.2013.08.010","volume":"4","author":"BL Taylor","year":"2013","unstructured":"Taylor BL, Liu FF, Sander M (2013) Nkx6.1 is essential for maintaining the functional state of pancreatic beta cells. Cell Rep 4:1262\u20131275","journal-title":"Cell Rep"},{"key":"3722_CR85","volume":"3","author":"B Blum","year":"2014","unstructured":"Blum B, Roose AN, Barrandon O et al (2014) Reversal of \u03b2 cell de-differentiation by a small molecule inhibitor of the TGF\u03b2 pathway. eLife 3:e02809","journal-title":"eLife"},{"key":"3722_CR86","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","volume":"5","author":"SC Burgess","year":"2007","unstructured":"Burgess SC, He T, Yan Z et al (2007) Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab 5:313\u2013320","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"3722_CR87","doi-asserted-by":"crossref","first-page":"v","DOI":"10.1111\/j.1463-1326.2011.01476.x","volume":"13","author":"JC Henquin","year":"2011","unstructured":"Henquin JC, Accili D, Ahren B, Boitard C, Seino S, Cerasi E (2011) Long in the shade, glucagon re-occupies centre court. Diabetes Obes Metab 13(Suppl 1):v\u2013viii","journal-title":"Diabetes Obes Metab"},{"key":"3722_CR88","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature06128","volume":"449","author":"R Dentin","year":"2007","unstructured":"Dentin R, Liu Y, Koo SH et al (2007) Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449:366\u2013369","journal-title":"Nature"},{"key":"3722_CR89","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.1151363","volume":"319","author":"R Dentin","year":"2008","unstructured":"Dentin R, Hedrick S, Xie J, Yates J 3rd, Montminy M (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319:1402\u20131405","journal-title":"Science"},{"key":"3722_CR90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature07349","volume":"456","author":"Y Liu","year":"2008","unstructured":"Liu Y, Dentin R, Chen D et al (2008) A fasting inducible switch modulates gluconeogenesis via activator\/coactivator exchange. Nature 456:269\u2013273","journal-title":"Nature"},{"key":"3722_CR91","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2012.03.002","volume":"15","author":"L Ozcan","year":"2012","unstructured":"Ozcan L, Wong CC, Li G et al (2012) Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metab 15:739\u2013751","journal-title":"Cell Metab"},{"key":"3722_CR92","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI200523096","volume":"115","author":"H Okamoto","year":"2005","unstructured":"Okamoto H, Obici S, Accili D, Rossetti L (2005) Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115:1314\u20131322","journal-title":"J Clin Invest"},{"key":"3722_CR93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1172\/JCI200421645","volume":"114","author":"H Okamoto","year":"2004","unstructured":"Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D (2004) Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114:214\u2013223","journal-title":"J Clin Invest"},{"key":"3722_CR94","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db09-1303","volume":"59","author":"HV Lin","year":"2010","unstructured":"Lin HV, Plum L, Ono H et al (2010) Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes 59:337\u2013346","journal-title":"Diabetes"},{"key":"3722_CR95","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cmet.2007.05.004","volume":"5","author":"AC Konner","year":"2007","unstructured":"Konner AC, Janoschek R, Plum L et al (2007) Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metab 5:438\u2013449","journal-title":"Cell Metab"},{"key":"3722_CR96","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1172\/JCI200525152","volume":"115","author":"AD Cherrington","year":"2005","unstructured":"Cherrington AD (2005) The role of hepatic insulin receptors in the regulation of glucose production. J Clin Invest 115:1136\u20131139","journal-title":"J Clin Invest"},{"key":"3722_CR97","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2337\/db10-1056","volume":"60","author":"HV Lin","year":"2011","unstructured":"Lin HV, Ren H, Samuel VT et al (2011) Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues. Diabetes 60:700\u2013709","journal-title":"Diabetes"},{"key":"3722_CR98","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/db12-1296","volume":"62","author":"K Tsuchiya","year":"2013","unstructured":"Tsuchiya K, Accili D (2013) Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance. Diabetes 62:1478\u20131489","journal-title":"Diabetes"}],"updated-by":[{"DOI":"10.1007\/s00125-015-3758-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000}}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-015-3722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3722-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T22:11:03Z","timestamp":1748556663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-015-3722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s00125-015-3722-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00125-015-3758-6","asserted-by":"object"}]},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}